Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in alopecia areata and factors influencing the outcome.

From: Journal of Drugs in Dermatology | Date: March 1, 2006| Author: Ajith, C.; Gupta, Somesh; Kanwar, Amrinder Jit | Copyright information

Abstract

Background: Immunotherapy with sqauric acid dibutyl ester (SADBE) is a well-accepted therapy for alopecia areata.

Objective: To study efficacy, safety, and factors influencing the outcome in the treatment of alopecia areata.

Method: During a 4-year period, 70 patients of alopecia areata, unresponsive to conventional therapies, were treated with SADBE for a period of 4 months and thereafter depending on the response with initial therapy. Th...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in alopecia areata and factors influencing the outcome.
Journal of Drugs in Dermatology ; Abstract Background: Immunotherapy with sqauric acid dibutyl ester (SADBE) is a well-accepted therapy for alopecia areata. Objective: To study efficacy, safety, and factors influencing the outcome in the treatment of alopecia areata. Method: During a 4-year period, 70 patients of alopecia areata,
Topical sensitizers in alopecia areata.(Disease Management)
Dermatology Nursing ; Though many therapies exist for alopecia areata, one of the most unique is topical sensitization. By altering the pathogenic inflammatory response with few side effects, sensitizers @r an attractive treatment option for many patients with alopecia areata, including those who have previously failed
Alopecia areata can be refractory to topical immunetherapy.(Washington Whispers)(Brief Article)
Journal of Drugs in Dermatology ; ALOPECIA AREATA CAN BE REFRACTORY TO TOPICAL immunetherapy. In this study, investigators evaluated the efficacy of SADBE (squaric acid dibutylester) topical immunotherapy combined with topical dry ice cryotherapy, carpronium chloride (a parasympathetic nerve stimulant), and/or oral cepharanthin (a
Alopecia areata.
American Family Physician ; Alopecia areata is an idiopathic, asymptomatic, nonscarring disorder characterized by single or multiple patches of well-demarcated hair loss (Figures 1 and 2). Males and females are equally affected; most patients are in the third to sixth decade. [1,2] Although the hair loss is usually localized,
Future of AA Tx
Dermatology Times ; Active research efforts expected to better patient management Chicago - Future advances in the management of patients with alopecia areata are expected to emerge from ongoing efforts aiming to facilitate clinical research studies and gain a better understanding of the immunological disease
Helping patients cope with chronic alopecia areata.(Disease Management)
Dermatology Nursing ; ... research and treatment. * A link to sign up for the national Alopecia Areata Registry. * A quarterly newsletter that includes news about research and treatment, personal stories, cosmetic tips, and KidNet, a special kids section. * An annual International ...
FISCAL 2000 LABOR HHS APPROPRIATIONS:JACKIE OMENITSCH
Congressional Testimony ; ... areata believe that they are vulnerable to the stares and grimaces of those around them. People have lost their jobs. A noted news anchor lost his on-air job because he was suddenly perceived as being unappealing. This lack of being appealing (either real ...
Scientists find evidence of genetic susceptibility for alopecia areata.(RESEARCH NEWS)(Clinical report)
Dermatology Nursing ; Scientists supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have identified loci on four chromosomes that appear to play a role in the development of alopecia areata, a common autoimmune disease characterized by patchy hair loss that can eventually
Alopecia universalis in Down syndrome: Response to therapy
Indian Journal of Dermatology, Venereology and Leprology ; Sir, Patients with Down syndrome have increased prevalence of common dermatological conditions like folliculitis, atopy and vitiligo, besides having increased incidence of peculiar dermatoses like syringomas, milia-like calcinosis, acanthosis nigricans and elastosis perforans serpiginosa.[12] The
Help patients with Alopecia Areata and win a free trip.(DNA NEWS)
Dermatology Nursing ; We are fortunate to have a natural partnership between the Dermatology Nurses Association (DNA) and the National Alopecia Areata Foundation (NAAF) to promote the Alopecia Areata Registry. With the DNA's mission highlighting the importance to develop and promote education and nursing leadership in